Clinical Trial: A Study to Evaluate the Safety, Tolerability and PK of SK-08

U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07021157) titled 'A Study to Evaluate the Safety, Tolerability and PK of SK-08' on May 12.

Brief Summary: The trial is conducted in a single-center, randomized, double-blind, placebo-controlled, dose-increasing design. To evaluate the safety, tolerability, pharmacokinetics(PK) ,and pharmacodynamics (PD) characteristics of SK-08 in healthy participants.

Study Start Date: March 09

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease(CKD)

Intervention: DRUG: SK-08

Dose groups of 5 mg, 7.5mg,12.5 mg, 30 mg, 45 mg, and 60 mg were given SK-08 once.

DRUG: Placebo

Dose groups of 5 mg, 7.5mg,12.5 mg, 30 mg, 45 mg, and 60 mg were given placebo...